BSE filing, NSE: ZIMLAB. Summary written from the filing by ALFA Finder's alert engine.
Zim Laboratories Ltd: key numbers
- Share price
- ₹143.10
- Market cap
- ₹767.9 Cr
- Revenue (annual)
- ₹374.4 Cr
- Net profit (annual)
- ₹5.84 Cr
- P/E (TTM)
- 207.8×Sector 46.5×
- Promoter holding
- 30.30%-0.06% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zim Laboratories Ltd
All →Zim Laboratories Regulatory Approval
Zim Laboratories received TGA GMP certification from Australia's Therapeutic Goods Administration for its Nagpur manufacturing facility. The certification covers various dosage forms and is valid until June 2028.
- From
- Therapeutic Goods Administration (TGA), Australia
Zim Laboratories Credit Rating
CARE Ratings has reaffirmed the credit ratings of Zim Laboratories Limited for its bank facilities, revising the outlook on long-term facilities to negative.
Zim Laboratories Other Announcement
Zim Laboratories Limited filed a certificate confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026.
Zim Laboratories Merger & Restructuring Worth ₹1,404,640 Cr
ZIM Laboratories completed incorporation of its wholly-owned Chilean subsidiary, ZIM Laboratories SpA. The LATAM expansion entity is now operational, marking completion of the February 2026 board-approved plan.
- Value
- ₹14,04,640 Cr
Zim Laboratories Merger & Restructuring
ZIM Laboratories Limited incorporated a wholly owned subsidiary, 'ZIM Laboratories SpA', in Chile. This expansion aims to develop its pharmaceutical business in the LATAM region.
Zim Laboratories Acquisition Worth ₹1.56 Cr
ZIM WOS completed a ₹1.56 Crore investment in stepdown ZIM Scientific Office L.L.C., Dubai, fulfilling the board-approved capital plan. The transaction closes the acquisition announced in August 2025.
- Value
- ₹1.56 Cr
Other board meeting date announcements
All →ESDS Software Solution Board Meeting Date
ESDS Software Solution will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for Q2 and half-year. This is a prior intimation of a future meeting with no decision yet taken.
Mrugesh Trading Board Meeting Date
Mrugesh Trading will hold a board meeting on 31 October 2026 to consider unaudited Q2 and half-year results. This is a prior intimation of a future meeting, with no decision yet taken.
Add-Shop E-Retail Board Meeting Date
Add-Shop E-Retail will hold a board meeting on 2 November 2026 to consider unaudited quarterly and half-year results. Video conferencing is the mode.
Polymechplast Machines Board Meeting Date
Polymechplast Machines will hold a board meeting on November 4, 2026 to consider unaudited half-year results. Trading window stays closed until 48 hours after the results.
Scarnose International Board Meeting Date
Scarnose International will hold a board meeting on 2 November 2026 to consider unaudited half-year results. The agenda remains proposed until the meeting occurs.
Nitin Castings Board Meeting Date
Nitin Castings will hold a board meeting on 2 November 2026 to consider September 2026 half-year unaudited results. Trading window stays closed until results are declared.